Dr. Reddy's Laboratories Ltd (RDY) Profit Margin History

Historical gross, operating and net quarterly profit margin for Dr. Reddy's Laboratories Ltd (RDY) over the last 10 years. The current net profit margin for Dr. Reddy's Laboratories Ltd as of April 20, 2018 is 6.95%.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.330B $2.171B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection